Amplia Therapeutics has today announced that Mr Tim Luscombe will replace Mr Hamish George as Chief Financial Officer (CFO) of the Company.
Mr Luscombe is a highly experienced Chartered Accountant who holds a Bachelor of Commerce from the University of Melbourne and a Certificate in Governance Practice from the Governance Institute of Australia. He is a Director at Bio101 Financial Advisory and has been working with Amplia in a senior accounting capacity over the last two years.
Amplia’s CEO and Managing Director, Dr Chris Burns, commented:
“We are delighted that Tim is taking on the role of CFO at Amplia. His knowledge of the company and close working relationship with the team means it will be a seamless transition. We would also like to thank Hamish for his excellent work over the previous years.”
Click here to read the ASX release.